Concepedia

Eric Lu

EL

12

Publications

735

Citations

11

H-Index

2017

Active since

Affiliations

Oregon Health & Science University(Current)

University of California, San Francisco

University of California, Los Angeles

University of Washington

University of Michigan

Eric Lu is an author at Oregon Health & Science University specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2017–2022

12

Publications

12

Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP Inhibitors

David A. Quigley, Joshi J. Alumkal, Alexander W. Wyatt et al. · Cancer Discovery · 2017 · 259 citations

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

Joshi J. Alumkal, Duanchen Sun, Eric Lu et al. · Proceedings of the National Academy of Sciences · 2020 · 166 citations · Full text

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

William S. Chen, Rahul Aggarwal, Li Zhang et al. · European Urology · 2019 · 139 citations · Full text

, , +10

Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing

Eric Lu, Kathryn E. Hatchell, Sarah M. Nielsen et al. · Cancer · 2021 · 28 citations · Full text

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2022 · 25 citations · Full text

, , +8

Rows per page

1–5 of 12